Hormone therapy for prostate cancer has come a long way in the past few decades. Not so long ago, the only hormonal treatment for this disease was drastic: an orchiectomy, the surgical removal of ...

Hormone therapy can make a big difference for men with recurrent or metastatic prostate cancer. But it isn't a cure. Its effects are limited and the side effects can be difficult to cope with.

as well as to monitor the effects of minimally invasive prostate cancer treatments in men who have not received hormone therapy. 23 Whether or not ultrasonography also has utility in men who have ...

that adding an AKT inhibitor to a standard-of-care therapy can provide benefit to patients with a biomarker of PTEN-deficient metastatic hormone-sensitive prostate cancer. “By targeting a key ...

If you have metastatic castration-resistant prostate cancer, the hormone therapy you’ve been taking is no longer controlling the disease as it should. Here’s what you should know. This type of ...

The trial utilizes the ArteraAI Prostate Test ... by determining cancer metastasis risk and identifying whether patients may be able to reduce or avoid hormone therapy. The trial is being led ...

And if you’re on hormone therapy, talk to your doctor about investing in some weights or elastic resistance bands to support your bone strength, too. Metastatic prostate cancer isn’t curable ...

SAN FRANCISCO -- Progression-free survival (PFS) in oligometastatic prostate cancer ... hormone-sensitive and resistant disease, stage, number of metastases, and prior androgen deprivation therapy ...

ABOUT 55,000 new prostate ... big the cancer is, whether it has spread anywhere else in your body, and your general health. But it can involve surgery, radiotherapy, hormone therapy and chemotherapy.

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or ...

Other treatments that patients diagnosed with prostate cancer may undergo include radical prostatectomy, which is the surgical removal of the prostate gland; radiotherapy; hormone therapy; and ...

Data derived from Yen T-T, et al. Comparative effects of glucagon-like peptide-1 receptor agonists combined with hormone therapy on endometrial cancer risk among women with benign uterine or ...